Exact Mass: 470.4334868
Exact Mass Matches: 470.4334868
Found 235 metabolites which its exact mass value is equals to given mass value 470.4334868,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
CE(5:0)
Cholesteryl pentanoate is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). Cholesteryl esters, formed by the esterification of cholesterol with long-chain fatty acids, on one hand, are the means by which cholesterol is transported through the blood by lipoproteins, on the other, the way cholesterol itself can be accumulated in the cells. (PMID: 15939411) [HMDB] Cholesteryl pentanoate is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). Cholesteryl esters, formed by the esterification of cholesterol with long-chain fatty acids, on one hand, are the means by which cholesterol is transported through the blood by lipoproteins, on the other, the way cholesterol itself can be accumulated in the cells. (PMID: 15939411).
DG(8:0/17:0/0:0)
DG(8:0/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/17:0)
DG(8:0/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/i-17:0/0:0)
DG(8:0/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/i-17:0)
DG(8:0/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/a-17:0/0:0)
DG(8:0/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/a-17:0)
DG(8:0/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/15:0/0:0)
DG(10:0/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/15:0)
DG(10:0/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/i-15:0/0:0)
DG(10:0/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/i-15:0)
DG(10:0/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/a-15:0/0:0)
DG(10:0/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/a-15:0)
DG(10:0/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/13:0/0:0)
DG(12:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/13:0)
DG(12:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/13:0/0:0)
DG(i-12:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/13:0)
DG(i-12:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/a-13:0/0:0)
DG(i-12:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/a-13:0)
DG(i-12:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/i-13:0/0:0)
DG(i-12:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/i-13:0)
DG(i-12:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/i-13:0/0:0)
DG(12:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/i-13:0)
DG(12:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/a-13:0/0:0)
DG(12:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/a-13:0)
DG(12:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(13:0/12:0/0:0)
DG(13:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(13:0/0:0/12:0)
DG(13:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/12:0/0:0)
DG(i-13:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/0:0/12:0)
DG(i-13:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/i-12:0/0:0)
DG(a-13:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/0:0/i-12:0)
DG(a-13:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/12:0/0:0)
DG(a-13:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/0:0/12:0)
DG(a-13:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/i-12:0/0:0)
DG(i-13:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/0:0/i-12:0)
DG(i-13:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(13:0/i-12:0/0:0)
DG(13:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(13:0/0:0/i-12:0)
DG(13:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(15:0/10:0/0:0)
DG(15:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(15:0/0:0/10:0)
DG(15:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-15:0/10:0/0:0)
DG(i-15:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-15:0/0:0/10:0)
DG(i-15:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-15:0/10:0/0:0)
DG(a-15:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-15:0/0:0/10:0)
DG(a-15:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(17:0/8:0/0:0)
DG(17:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(17:0/0:0/8:0)
DG(17:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-17:0/8:0/0:0)
DG(i-17:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-17:0/0:0/8:0)
DG(i-17:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-17:0/8:0/0:0)
DG(a-17:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-17:0/0:0/8:0)
DG(a-17:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
11beta-Aethoxy-alpha-amyrin = 3beta-Hydroxy-11Beta-aethoxy-Delta12-ursen
24alpha-ethyllophenol acetate|24beta-Ethyllophenol acetate
14alpha-Methyl-24alpha-ethylcholest-9(11)-enol acetate
14,15-seco-urs-18betaH-20(30)-en-3beta-yl acetate|plucheaursenyl acetate
24-isopropyl-5alpha-cholest-22Z-en-3beta-ol acetate
(E)-N-[(20S)-20-(dimethylamino)-5alpha-pregnan-3beta-yl]-N,3,4-trimethylpent-2-enamide|saligenamide-A|Salignenamide F|salignenamide-F
C31H54N2O (470.42359139999996)
4alpha,23,24-trimethylcholest-22-en-3beta-yl acetate
(3beta,23R)-3-methoxy-24-methylenelanost-8-en-23-ol
(4aR)-10c-Acetoxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen|3beta-Acetoxy-18alpha.19betaH.20alphaH-ursan|3beta-Acetoxy-taraxastan|3beta-acetoxy-taraxastane|Taraxastanyl-(3beta)-acetat|taraxasterol acetate|Taraxasterylacetat
CE(5:0)
Hopane-29-acetate
A hopanoid that is hopane substituted by an acetoxy group at position 29.
Tetracosanoic acid, 2-[(trimethylsilyl)oxy]-, methyl ester
C28H58O3Si (470.41549979999996)
Trimethylsilyl 24-methylenecholesterol
C31H54OSi (470.39437139999995)
[(2S)-3-dodecanoyloxy-2-hydroxypropyl] tridecanoate
(3-Carboxy-2-henicosanoyloxypropyl)-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(10-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(19-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(13-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(9-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(17-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(16-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(8-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(7-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(6-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(12-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(3-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(4-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(14-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(18-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(15-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(11-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(5-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-carboxy-2-[(E)-3-hydroxyicos-13-enoyl]oxypropyl]-trimethylazanium
C27H52NO5+ (470.38452820000003)
[3-carboxy-2-[(E)-3-hydroxyicos-11-enoyl]oxypropyl]-trimethylazanium
C27H52NO5+ (470.38452820000003)
Triptohypol D
A pentacyclic triterpenoid with formula C32H54O2, originally isolated from the root bark of Tripterygium hypoglaucum.
[(2R)-3-carboxy-2-henicosanoyloxypropyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
(1-Hydroxy-3-nonanoyloxypropan-2-yl) hexadecanoate
(1-Dodecanoyloxy-3-hydroxypropan-2-yl) tridecanoate
(1-Hydroxy-3-undecanoyloxypropan-2-yl) tetradecanoate
(1-Decanoyloxy-3-hydroxypropan-2-yl) pentadecanoate
(1-Heptanoyloxy-3-hydroxypropan-2-yl) octadecanoate
(1-Hexanoyloxy-3-hydroxypropan-2-yl) nonadecanoate
(1-Butanoyloxy-3-hydroxypropan-2-yl) henicosanoate
(1-Hydroxy-3-octanoyloxypropan-2-yl) heptadecanoate
[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] tetradecanoate
[(2S)-3-hydroxy-2-undecanoyloxypropyl] tetradecanoate
(14Z,17Z,20Z,23Z,26Z)-dotriacontapentaenoic acid
A very long-chain omega-6 fatty acid that is dotriacontapentaenoic acid having five double bonds located at positions 14, 17, 20, 23 and 26 (the 14Z,17Z,20Z,23Z,26Z-isomer).
(17Z,20Z,23Z,26Z,29Z)-dotriacontapentaenoic acid
A very long-chain omega-3 fatty acid that is dotriacontapentaenoic acid having five double bonds located at positions 17, 20, 23, 26 and 29 (the 17Z,20Z,23Z,26Z,29Z-isomer).
n-{1-[1-(dimethylamino)ethyl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl}-n,3,4-trimethylpent-2-enamide
C31H54N2O (470.42359139999996)
(1r,3ar,5ar,7s,9ar,9br,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
3-[(3r,3ar,5as,6r,9ar,9br)-6,9a,9b-trimethyl-3-[(2r)-6-methylhept-5-en-2-yl]-7-(propan-2-ylidene)-octahydro-1h-cyclopenta[a]naphthalen-6-yl]propyl acetate
(1r,3ar,5ar,5br,7ar,9r,10r,11ar,11bs,13ar,13br)-10-methoxy-3a,5a,5b,7a,8,8,11a-heptamethyl-1-(prop-1-en-2-yl)-tetradecahydro-1h-cyclopenta[a]chrysen-9-ol
(1r,3ar,5ar,7s,9as,11ar)-1-[(2s,3s,5z)-3-hydroxy-5-isopropylhept-5-en-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-ol
7,20-diethyl-1,7,11,16,20-pentamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-ene-8,19-diol
6-{7-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-3-methylideneheptan-4-ol
3-[6,9a,9b-trimethyl-3-(6-methylhept-5-en-2-yl)-7-(propan-2-ylidene)-octahydro-1h-cyclopenta[a]naphthalen-6-yl]propyl acetate
(1r,7r,9r,15r,21s,23s,29r,30s)-9,23-dimethyl-11,25-diazapentacyclo[19.7.1.1⁷,¹¹.0²⁵,²⁹.0¹⁵,³⁰]triacontane-8,22-dione
2-[(3s,3as,5ar,5br,7as,11as,11br,13ar,13bs)-5a,5b,8,8,11a,13b-hexamethyl-hexadecahydrocyclopenta[a]chrysen-3-yl]propan-2-yl acetate
(2r)-2-[(3s,3as,5ar,5br,7as,11as,11br,13ar,13bs)-5a,5b,8,8,11a,13b-hexamethyl-hexadecahydrocyclopenta[a]chrysen-3-yl]propyl acetate
14-ethoxy-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-ol
n-[(1r,3r,6r,8s,11s,12s,15s,16r)-15-[(1s)-1-(dimethylamino)ethyl]-7,7,12,16-tetramethyl-18-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]butanimidic acid
(1s,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-1-isopropyl-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
(3s,6ar,6bs,8ar,11r,12s,14r,14bs)-14-ethoxy-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-ol
(1r,3ar,5as,6s,7s,9as,9br,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-6,9a,11a-trimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
9,23-dimethyl-11,25-diazapentacyclo[19.7.1.1⁷,¹¹.0²⁵,²⁹.0¹⁵,³⁰]triacontane-8,22-dione
(1r,7s,9s,15r,21s,23s,29r,30r)-9,23-dimethyl-11,25-diazapentacyclo[19.7.1.1⁷,¹¹.0²⁵,²⁹.0¹⁵,³⁰]triacontane-8,22-dione
(2e)-n-[(1s,3as,3br,5as,7s,9as,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]-n,3,4-trimethylpent-2-enamide
C31H54N2O (470.42359139999996)